<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p><strong><u>BURULI ULCER</u></strong></p><p>This is a chronic painless necrotizing ulcer with undermined edges, which can lead to debilitating skin and soft tissue infection and permanent disfigurement. While it is known that this ulcer is caused by a bacterium, the mode of transmission remains unclear. However, trauma, insect bite and inhalation have been suggested.</p><p>When detected early, the majority can be cured with a combination of antibiotics. Thus, early identification and appropriate management reduce morbidity and disability from this condition.</p><p> </p><p><strong>CAUSES</strong></p><ul><li><i>Mycobacterium ulcerans</i></li></ul><p> </p><p><strong>SYMPTOMS</strong></p><ul><li>Painless subcutaneous nodule</li><li>Painless swelling of the legs, arms or face</li><li>Extensive skin ulceration</li></ul><p> </p><p><strong>SIGNS</strong></p><ul><li>Nodule: Painless firm lesion 1-2 cm in diameter situated in the subcutaneous tissue and attached to the skin</li><li>Diffuse painless swelling of the legs, arms or face</li><li>Large painless area of induration</li><li>Extensive skin ulceration</li></ul><p> </p><p><strong>INVESTIGATIONS</strong></p><ul><li>Wound swab for AFBs, bacterial cultures and sensitivity</li><li>Skin biopsy for histopathology</li></ul><p> </p><p><strong>TREATMENT</strong></p><p><strong>Treatment objectives</strong></p><ul><li>To limit the extent of tissue destruction</li><li>To prevent disability</li><li>To treat both primary and secondary bacterial infection</li></ul><p><strong>Non-pharmacological treatment</strong></p><ul><li>Complete excision of nodules, preferably with primary closure if possible</li><li>Skin grafting of ulcers if facilities are available</li></ul><p><strong>Pharmacological treatment 1<sup>st</sup> Line Treatment Evidence Rating: [A]</strong></p><ul><li>Rifampicin, oral, 10 mg/kg daily for 8 weeks</li></ul><p><strong>And</strong></p><ul><li>Streptomycin, IM, 15 mg/kg daily for 8 weeks</li></ul><p><strong>2<sup>nd</sup> Line Treatment Evidence Rating: [C]</strong></p><ul><li>Rifampicin, oral, 10 mg/kg daily for 8 weeks</li></ul><p><strong>And</strong></p><ul><li>Clarithromycin, oral, 7.5 mg/kg 12 hourly for 8 weeks</li></ul><p><strong>REFERRAL CRITERIA</strong></p><p>Refer to centres with expertise for managing buruli ulcer.</p><p> </p>
</body>
</html>
